Page 17 - Collaborative Research News Today

- Kirin Holdings Company, Limited (TOKYO:2503) and Kao Corporation (TOKYO:4452) will participate in the Wakayama Health Promotion Study, a cohort study*2 led ...

Kirin Holdings Company Limited TOKYO2503 and Kao Corporation TOKYO4452 will participate in the Wakayama Health Promotion Study a cohort study2 led by Wakayama Medical University and organized by the Health Promotion Research Center HPRC a nonprofit organization.

1

Hadron Therapy MarketThe hadron therapy market is anticipated to capture a valuation of US$ 1.5 billion in 2023 and US$ 4.7 billion by 2033. The global market is estimated to secure a CAGR of 11.9% during the forecast period.The proton therapy segment is expected to account for the largest share of the hadron therap...

Daily review is also your post. This provides Standardistas the opportunity to review events of the day. The usual rules of good behaviour apply (see the Policy). Don’t forget to be kind to each other …

Antimicrobial resistance (AMR) is currently considered among the most significant hurdles of the 21st century.

Open mike is your post. For announcements, general discussion, whatever you choose. The usual rules of good behaviour apply (see the Policy). Step up to the mike …

Open mike is your post. For announcements, general discussion, whatever you choose. The usual rules of good behaviour apply (see the Policy). Step up to the mike …

1

1